Training program to promote diversity in cancer research

促进癌症研究多样性的培训计划

基本信息

项目摘要

Summary Disparities in cancer incidence and mortality rates among different ethnic/racial groups has been well recognized; however, research in this area has lagged behind, partly due to a shortage of cancer researchers and physicians from underrepresented minorities. North Carolina is among the most diverse states in the nation, and ranks ninth with respect to African American population. African Americans, Hispanics/Latinos, and Native Americans are 33% of the state's population. Accordingly, there is obvious cancer disparity. Thus, we created the “North Carolina Summer Undergraduate Prostate Cancer Research Program (NC-SUPR)” which offers summer research experiences to undergraduates from two local HBCUs. The program was supported by the Department of Defense for the last two years, and successfully implemented. Based on this fruitful experience, we have arranged a larger consortium of “Cancer Equity Research Training at North Carolina (CERT-NC)” by four Universities, including two local HBCUs. We now propose to create a new R25 training program for promoting diversity of cancer research at Wake Forest Baptist Comprehensive Cancer Center (WFBCCC). The objective of this training program is to promote and enhance diversity of the future cancer research workforce, by providing undergraduates from under-represented populations with opportunities for short-term research experiences. Our Specific Aims are to: (i) Recruit highly qualified underrepresented minority undergraduates through CERT-NC and nationwide; (ii) Engage participants in hands-on research activities in basic and translational laboratories and expose them to cutting-edge cancer research; (iii) Provide mentorship and guidance to participants for their career development; and (iv) Guide students in future career development and track their progress. Our proposed program includes multiple innovative approaches. First, it will build on the experience of the successful NC-SUPR program, while expanding its scope. Second, the program will use the unique consortium, CERT-NC, which consists of WFBCCC, two local HBCUs, and another regional college with a large enrollment of Native Americans. Third, we will implement the “Ambassador program”, which provides students with community outreach experience. Fourth, the program's distinguished faculty will provide education so that participants achieve a grasp of cancer biology basics and learn about state-of-the-art technologies for precision medicine and drug development. Fifth, the program offers career guidance from underrepresented minority faculty as “Career mentors”. Lastly, the program will be strengthened by interactions with other summer research programs at Wake Forest University. Thus, participants will interact with other underrepresented minority students and establish peer networks for future career development. Our program features faculty committed to mentorship and a diverse scientific environment with exposure to cutting-edge approaches to cancer biology, and can implement proven methods for recruitment and follow-up for efficient and effective administration of a vibrant training program.
总结 不同族裔/种族群体之间癌症发病率和死亡率的差异一直很好。 然而,这一领域的研究已经落后,部分原因是缺乏癌症研究人员。 以及来自弱势群体的医生。北卡罗来纳州是美国最多样化的州之一。 在非洲裔美国人中排名第九。非裔美国人,西班牙裔/拉丁裔,以及 印第安人占该州人口的33%。因此,存在明显的癌症差异。因此我们 创建了“北卡罗来纳州夏季大学生前列腺癌研究计划(NC-SUPR)”, 提供暑期研究经验,从两个本地HBCU的本科生。该计划得到了 在过去的两年里,国防部,并成功地实施。基于这一富有成果的 根据经验,我们已经安排了一个更大的财团“癌症公平研究培训在北卡罗来纳州 (CERT-NC)”,由四所大学,包括两个地方HBCU。我们现在建议创建一个新的R25培训 维克森林浸信会综合癌症中心促进癌症研究多样性的计划 (WFBCCC)。该培训计划的目标是促进和提高未来癌症的多样性 研究人员,通过为代表性不足的人口提供机会, 短期研究经验。我们的具体目标是:㈠征聘任职人数不足的高素质人员 通过CERT-NC和全国范围内的少数民族大学生;(二)让参与者参与实践研究 在基础和转化实验室开展活动,让他们接触最前沿的癌症研究; ㈢提供 为参加者的职业发展提供师友和指导;及(iv)为学生的未来职业提供指导 发展并跟踪其进展。我们提出的方案包括多种创新方法。一是 将建立在成功的NC-SUPR计划的经验,同时扩大其范围。二是 该计划将使用独特的财团,CERT-NC,其中包括WFBCCC,两个当地HBCU, 另一所招收大量美洲原住民的地区学院。第三,我们会落实 “大使计划”,为学生提供社区外展经验。第四,方案的 杰出的教师将提供教育,使参与者掌握癌症生物学基础知识, 了解精准医疗和药物开发的最新技术。五、方案 作为“职业导师”,为代表性不足的少数族裔教师提供职业指导。最后,该计划将 通过与维克森林大学其他暑期研究项目的互动,加强了这一点。因此,在本发明中, 参与者将与其他代表性不足的少数民族学生互动,并为未来建立同龄人网络。 职业发展。我们的计划具有教师致力于指导和多元化的科学 接触癌症生物学前沿方法的环境,并可以实施经过验证的方法 招聘和后续工作,以便高效和有效地管理充满活力的培训计划。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEVEN J. KRIDEL其他文献

STEVEN J. KRIDEL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEVEN J. KRIDEL', 18)}}的其他基金

Training program to promote diversity in cancer research
促进癌症研究多样性的培训计划
  • 批准号:
    9789232
  • 财政年份:
    2018
  • 资助金额:
    $ 9.49万
  • 项目类别:
Training program to promote diversity in cancer research
促进癌症研究多样性的培训计划
  • 批准号:
    10450628
  • 财政年份:
    2018
  • 资助金额:
    $ 9.49万
  • 项目类别:
Training program to promote diversity in cancer research
促进癌症研究多样性的培训计划
  • 批准号:
    9999521
  • 财政年份:
    2018
  • 资助金额:
    $ 9.49万
  • 项目类别:
NAD+ metabolism in prostate cancer
前列腺癌中的 NAD 代谢
  • 批准号:
    9036948
  • 财政年份:
    2012
  • 资助金额:
    $ 9.49万
  • 项目类别:
NAD+ metabolism in prostate cancer
前列腺癌中的 NAD 代谢
  • 批准号:
    8657918
  • 财政年份:
    2012
  • 资助金额:
    $ 9.49万
  • 项目类别:
NAD+ metabolism in prostate cancer
前列腺癌中的 NAD 代谢
  • 批准号:
    8508894
  • 财政年份:
    2012
  • 资助金额:
    $ 9.49万
  • 项目类别:
Fatty acid synthase inhibitors and prostate cancer
脂肪酸合酶抑制剂与前列腺癌
  • 批准号:
    7146332
  • 财政年份:
    2006
  • 资助金额:
    $ 9.49万
  • 项目类别:
Fatty acid synthase inhibitors and prostate cancer
脂肪酸合酶抑制剂与前列腺癌
  • 批准号:
    7658128
  • 财政年份:
    2006
  • 资助金额:
    $ 9.49万
  • 项目类别:
Fatty acid synthase inhibitors and prostate cancer
脂肪酸合酶抑制剂与前列腺癌
  • 批准号:
    7895851
  • 财政年份:
    2006
  • 资助金额:
    $ 9.49万
  • 项目类别:
Fatty acid synthase inhibitors and prostate cancer
脂肪酸合酶抑制剂与前列腺癌
  • 批准号:
    7280912
  • 财政年份:
    2006
  • 资助金额:
    $ 9.49万
  • 项目类别:

相似海外基金

Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    8013895
  • 财政年份:
    2008
  • 资助金额:
    $ 9.49万
  • 项目类别:
Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    7462657
  • 财政年份:
    2008
  • 资助金额:
    $ 9.49万
  • 项目类别:
Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    7755368
  • 财政年份:
    2008
  • 资助金额:
    $ 9.49万
  • 项目类别:
Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    7586197
  • 财政年份:
    2008
  • 资助金额:
    $ 9.49万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10132461
  • 财政年份:
    1997
  • 资助金额:
    $ 9.49万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10331060
  • 财政年份:
    1997
  • 资助金额:
    $ 9.49万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10597891
  • 财政年份:
    1997
  • 资助金额:
    $ 9.49万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10178913
  • 财政年份:
    1997
  • 资助金额:
    $ 9.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了